Our clinical validation focused on the top candidate from our bioinformatics analysis, IFIT3. We confirmed that IFIT3 expression was significantly upregulated in the blood of individuals with TB (including PTB and EPTB subgroups) compared to healthy controls, highlighting its potential as a general TB biomarker. Here, IFIT3 is linked to tuberculosis.